Recon: FDA approves Lilly's Verzenio for early breast cancer; Ebola vaccination campaign begins in Congo
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy